Humasis has 344.6 billion won in cashable assets (including short-term financial products) as of the third quarter of last year by developing and selling COVID-19 diagnostic kits.
Shares of Humasis are fluctuating as minority shareholders are pushing to replace management demanding cash dividends at a time when their stakes in major shareholders are low. According to the financial investment industry on the 11th, Humasis' extraordinary shareholders' meeting is scheduled for the 28th of next month. Minority shareholders submit three agenda items to the extraordinary shareholders' meeting, including changes in the articles of incorporation, the appointment of directors, and the appointment of full-time auditors. It is Koo Hee-chul who is leading this conflict. He holds a total of 5.45% stake in related parties. Currently, it holds a 7.58% stake in Cha Jung-hak, CEO of Humasis, a major shareholder, and related parties. Koo appeared as a candidate for the standing audit. Humasis also plans to propose an agenda before the shareholders' meeting. Humasis announced on the 4th that Koo applied for an injunction to the Anyang branch of the Suwon District Court to allow him to view and copy the list of shareholders in a management dispute suit. As of the end of September last year, assuming that the stakes of Koo and Cha were maintained, the difference was only 2.13 percentage points. As minority shareholders have a 78.12% stake, the two sides are expected to have a hot vote. As the dispute between the two sides begins in earnest, Humasis shares are also fluctuating due to rumors. Humasis closed at 18,500 won, up 1,400 won (8.19%).
Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)
